Globe Life director granted 6,433 stock options

GLOBE LIFE INC. director Derek T. Kan received a grant of 6,433 Director Stock Options on March 18, 2026.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

GLOBE LIFE INC. director Derek T. Kan received a grant of 6,433 Director Stock Options on March 18, 2026. These options give him the right to buy 6,433 shares of common stock at an exercise price of $137.62 per share until March 18, 2033.

Following this award, he directly holds 6,433 options and no shares of common stock, either directly or indirectly, according to the reported holdings.

Insider Trade Summary

Grant/Award: 6,433 shares

Grant/Award 3 txns

Insider Kan Derek T.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Stock Option (Right to Buy)	6,433	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Director Stock Option (Right to Buy) — 6,433 contracts (Direct); Common Stock — 0 shares (Direct); Common Stock — 0 shares (Indirect, Not Applicable)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Derek T. Kan report at GLOBE LIFE INC. (GL)?

Director Derek T. Kan reported receiving 6,433 Director Stock Options in GLOBE LIFE INC. on March 18, 2026. These options are a compensation-related grant, giving him the right to purchase common shares at a fixed exercise price rather than reflecting an open-market trade.

How many GLOBE LIFE INC. options did Derek T. Kan receive and at what price?

He received 6,433 Director Stock Options with an exercise price of $137.62 per share. This means he can buy up to 6,433 GLOBE LIFE INC. common shares at $137.62 each if he chooses to exercise the options before they expire.

When do Derek T. Kan’s GLOBE LIFE INC. stock options expire?

The granted Director Stock Options expire on March 18, 2033, giving a long window to exercise. Until that expiration date, he can choose to purchase GLOBE LIFE INC. common stock at the fixed exercise price of $137.62 per share under this grant.

Does Derek T. Kan currently hold GLOBE LIFE INC. common stock after this Form 4?

After this Form 4 event, the reported holdings show zero shares of GLOBE LIFE INC. common stock, both directly and indirectly. Instead, his position consists of 6,433 Director Stock Options, which are rights to buy shares in the future at a set price.

Is Derek T. Kan’s GLOBE LIFE INC. option grant an open-market purchase or a compensation award?

The transaction is categorized as a grant or award acquisition, not an open-market purchase. He received 6,433 Director Stock Options at no cost, reflecting equity-based compensation rather than buying existing GLOBE LIFE INC. shares on the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/19/2026 - 05:05 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kan Derek T.

(Last)

(First)

(Middle)

C/O GLOBE LIFE INC.

7677 HENNEMAN WAY

(Street)

MCKINNEY

TEXAS

75070

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GLOBE LIFE INC. [ GL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								0	D
Common Stock								0	I	Not Applicable

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Director Stock Option (Right to Buy)	$137.62	03/18/2026		A		6,433		09/18/2026	03/18/2033	Common Stock	6,433	$0	6,433	D

Explanation of Responses:

	Derek T. Kan, By /s/ Chris T. Moore, Attorney-in-fact	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR